Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene

被引:41
作者
Erichsen, Thomas J. [1 ]
Ehmer, Ursula [1 ]
Kalthoff, Sandra [1 ]
Lankisch, Tim O. [1 ]
Mueller, Tordis M. [1 ]
Munzel, Peter A. [2 ]
Manns, Michael P. [1 ]
Strassburg, Christian R. [1 ]
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[2] Univ Tubingen, Dept Toxicol, Inst Pharmacol & Toxicol, Tubingen, Germany
关键词
UDP glucuronosyltransferase; transcriptional regulation; nuclear receptor; single nucleotide polymorphism; UGT1A4; xenobiotic response element;
D O I
10.1016/j.taap.2008.02.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP glucuronosyltransferases (UGTs) play an important role for drug detoxification and toxicity. UGT function is genetically modulated by single nuclecticle polymorphisms (SNPs) which lead to the expression of functionally altered protein, or altered expression levels. UGT1A4 activity includes anticonvulsants, antidepressants and environmental mutagens. In this study the induction of the human UGT1A4 gene and a potential influence of genetic variation in its promoter region were analyzed. SNPs at bp -219 and - 163 UGTI A4 i i i i b 40% transcr pt on was occurred in 9% among 109 blood donors reducing UGTlA4 transcr pt on y. dioxin inducible. Reporter gene experiments identified 2 xenobiotic response elements (XRE), which were functionally confirmed by mutagenesis analyses, and binding was demonstrated by electromobility shift assays. Constitutive human UGTIA4 gene expression and induction was aryl hydrocarbon receptor (AhR)dependent, and reduced in the presence ofSNPs at bp -219 and - 163. AhR-mediated regulation of the human UGTIA4 gene by two XRE and a modulation by naturally occurring genetic variability by SNPs is demonstrated, which indicates gene-environment interaction with potential relevance for drug metabolism. (c) 2008 Elsevier Inc. All rights reserved
引用
收藏
页码:252 / 260
页数:9
相关论文
共 41 条
[11]  
Guillemette C, 2000, CANCER RES, V60, P950
[12]   CLONING AND SUBSTRATE-SPECIFICITY OF A HUMAN PHENOL UDP-GLUCURONOSYLTRANSFERASE EXPRESSED IN COS-7 CELLS [J].
HARDING, D ;
FOURNELGIGLEUX, S ;
JACKSON, MR ;
BURCHELL, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) :8381-8385
[13]  
Hiller A, 1999, DRUG METAB DISPOS, V27, P605
[14]   Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4 [J].
Kaku, T ;
Ogura, K ;
Nishiyama, T ;
Ohnuma, T ;
Muro, K ;
Hiratsuka, A .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (11) :2093-2102
[15]   Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene [J].
Lankisch, TO ;
Vogel, A ;
Eilermann, S ;
Fiebeler, A ;
Krone, B ;
Barut, A ;
Manns, MP ;
Strassburg, CP .
MOLECULAR PHARMACOLOGY, 2005, 67 (05) :1732-1739
[16]   UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation [J].
Mori, A ;
Maruo, Y ;
Iwai, M ;
Sato, H ;
Takeuchi, Y .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (05) :672-675
[17]   Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells [J].
Münzel, PA ;
Schmohl, S ;
Buckler, F ;
Jaehrling, J ;
Raschko, FT ;
Köhle, C ;
Bock, KW .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (05) :841-847
[18]   Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6 [J].
Münzel, PA ;
Lehmköster, T ;
Brück, M ;
Ritter, JK ;
Bock, KW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 350 (01) :72-78
[19]   UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer [J].
Ockenga, J ;
Vogel, A ;
Teich, N ;
Keim, V ;
Manns, MP ;
Strassburg, CP .
GASTROENTEROLOGY, 2003, 124 (07) :1802-1808
[20]  
PILLOT T, 1993, J BIOL CHEM, V268, P25636